Advertisement
Table 3 Longitudinal analyses for main linear mixed models (n-114). Parameter estimates and CI intervals for treatment effects in outcomes, after experimental intervention compared to usual care
| Outcome measure | Estimated regression coefficient {95% CI } P-value (two-tailed) |
|---|---|
| Primary outcomes | |
| RDQ (0–24) | -1.6 {-2.9;-0.5} 0.005 |
| MC (VAS) * (0–100) | -4.9 {-10.3;0.4} 0.07 |
| Secondary outcomes | |
| VAS (pain today) (0–100) | -1.4 {-6.6;3.8} 0.58 |
| VAS (pain this week) (0–100) | -3.6 {-9.3;2.0} 0.20 |
| Secondary outcomes | |
| IPA: | |
| Autonomy in self-care (0–28) | -1.0 {-1.9;-0.03} 0.04 |
| Mobility and leisure (0–20) | -0.4 {-1.3;0.5} 0.40 |
| Family role (0–28) | -0.7 {-1.9;0.5} 0.27 |
| Social relationships (0–24) | -0.3 {-0.8;0.2} 0.23 |
| TSK: | |
| Total score (17–68) | -2.4 {-3.8;-1.1} 0.00 |
| Activity Avoidance (8–32) ‡ | -1.7 { -2.6;-0.8} 0.00 |
| Harm (5–20) † | -0.3 {-0.8;0.2} 0.23 |
| SF-36: | |
| General Health (0–100) | -0.7 {-3.3;1.8} 0.57 |
| EuroQol (0–1) | -0.005 {-0.04;0.03} 0.87 |
| Subgroup RDQ < 13 | |
| TSK (total) (17–68) | -1,9 {-3.6;-0.15} 0.03 |
| Activity Avoidance (8–32)(TSK-subscale) | -1.3 {-2.3;-0.3} 0.02 |
| Subgroup RDQ ≥ 13 | |
| RDQ (0–24) | -1.8 {-3.4:-0.14} 0.03 |
| Autonomy in self-care (0–28)(IPA subscale) | -1.7 {-3.0;-0.4} 0.01 |
| Activity Avoidance (8–32)(TSK subscale) | -1.5 {-2.7;-0.3} 0.01 |
